Sign in

CIK 0001439222

  • Large accelerated filer

AGIOS PHARMACEUTICALS, INC.

Sign in to watch
Ticker
AGIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 617-649-8600
Business address
88 SIDNEY STREET, CAMBRIDGE, MA, 02139
Former names
AGIOS PHARMACEUTICALS INC
  1. 4 Open-market sale Chief Executive Officer sold 23,572 shares at an average $81.09 ($1,911,494)
  2. 4 Open-market sale Principal Accounting Officer sold 2,150 shares at $75.00 ($161,250)
  3. 4 Open-market sale Chief Executive Officer sold 20 shares at $80.01 ($1,600)
  4. 4/A Derivatives Options or other derivatives
  5. 4 Open-market sale Chief Commercial Officer sold 25,000 shares at $74.83 ($1,870,750)
  6. 4 Open-market sale Chief Executive Officer sold 46,408 shares at $80.01 ($3,713,104)
  7. 4/A Derivatives Options or other derivatives
  8. 4 Open-market buy 10% owner bought 851,154 shares at $67.00 ($57,027,318)
  9. 4 Open-market sale Chief Executive Officer sold 53,000 shares at an average $73.16 ($3,877,218)
  10. 4 Open-market sale Chief Scientific Officer sold 3,000 shares at $65.00 ($195,000)
  11. 4 Open-market sale Director sold 3,838 shares at an average $59.37 ($227,857)
  12. 4 Exercise or conversion Chief Scientific Officer acquired 46,795 shares (option exercise)
  13. 4 Open-market sale Chief Executive Officer sold 6,000 shares at an average $61.55 ($369,288)
  14. 4 Derivatives Options or other derivatives
  15. 4 Open-market sale Chief Scientific Officer sold 2,146 shares at an average $60.79 ($130,459)
  16. 3 Insider Initial Statement of Ownership
  17. 4 Open-market sale Director sold 4,000 shares at an average $60.88 ($243,540)
  18. 4 Open-market sale Chief Scientific Officer sold 2,146 shares at an average $62.69 ($134,522)
  19. 4 Open-market sale Chief Executive Officer sold 6,000 shares at an average $63.85 ($383,105)
  20. 4 Open-market sale Director sold 4,000 shares at an average $71.10 ($284,380)

Page 23 of 38 · 758 filings